APPLICATION
ANDA075635
TYPE
ANDA
ORIGINAL APPROVAL
2001-09-19
LATEST ACTION
2018-04-23
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
ETOPOSIDEPrescription
ETOPOSIDE 50MG · CAPSULE · ORAL
Approval history
2018-04-23Labeling · Supplement 13 · standardAP
2006-08-29Labeling · Supplement 8AP
2004-05-28Labeling · Supplement 4AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.